## ALB: Albemarle Corporation - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 7.6% in mid entry zone (4.0-10.0%), top 8% cross-sectional ranking. Caution: MRS_5 (-1.6%) diverging from MRS_20, watch for reversal. Outperforming sector by 7.1%. Caution: momentum weakening (-8.2% MRS).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($114.29)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 7
- **Sentiment:** Bullish (Bullish: 2, Bearish: 0)

**1. Baird Raises Albemarle (ALB) Price Target as Lithium Market Optimism Grows**
- Source: Finviz | 20251203T145600 | Bullish | Relevance: 100%
- Baird upgraded Albemarle Corporation (ALB) to Neutral from Underperform and increased its price target to $113 from $81, citing optimism around lithium demand for energy storage, particularly in stationary storage. The company reported strong Q3 2025 results with revenues of $1.3 billion and adjusted EBITDA up 7%, and expects to generate positive free cash flow of $300-$400 million for the full year. Albemarle is also divesting stakes in Ketjen and a joint venture for approximately $660 million in pre-tax proceeds.

**2. Baird Raises Albemarle (ALB) Price Target as Lithium Market Optimism Grows**
- Source: Insider Monkey | 20251203T145600 | Bullish | Relevance: 100%
- Baird upgraded Albemarle (ALB) to Neutral from Underperform and raised its price target to $113 from $81, citing optimism around lithium demand for energy storage. Albemarle reported strong Q3 2025 results with revenues of $1.3 billion and adjusted EBITDA up 7% to $226 million, expecting positive free cash flow of $300â€“$400 million for the full year 2025. The company is also divesting stakes in Ketjen and Eurecat for approximately $660 million, strengthening its financial position.

**3. Quantbot Technologies LP Acquires 64,763 Shares of Albemarle Corporation $ALB**
- Source: MarketBeat | 20251203T133248 | Somewhat-Bullish | Relevance: 100%
- Quantbot Technologies LP increased its stake in Albemarle Corporation by 36.2% in Q2, acquiring 64,763 shares, bringing its total to 243,551 shares valued at $15.263 million. Other institutional investors like ProShare Advisors LLC, FengHe Fund Management Pte. Ltd., PGGM Investments, Norges Bank, and Nuveen LLC also increased or initiated positions, resulting in institutional ownership of 92.87%. Albemarle recently reported an EPS beat, announced a quarterly dividend of $0.405 per share, and received updated price targets and ratings from several analysts.

**4. Rhumbline Advisers Lowers Stake in Albemarle Corporation $ALB**
- Source: MarketBeat | 20251201T105205 | Neutral | Relevance: 100%
- Rhumbline Advisers reduced its stake in Albemarle Corporation by 2.0% in the second quarter, selling 4,730 shares but still holding 236,207 shares valued at $14.8 million. Despite this, institutional ownership of Albemarle remains high at 92.87%, with several other funds increasing their positions. Analysts maintain a "Hold" rating with a consensus target price of $101.29, although recent price target adjustments from firms like Jefferies and Deutsche Bank show varied outlooks.

**5. Here Are Tuesday's Top Wall Street Analyst Research Calls: Albemarle, Circle Internet, Cloudflare, Danaher, Inspire Medical, Six Flags, Workday and More**
- Source: 24/7 Wall St. | 20251202T131551 | Somewhat-Bullish | Relevance: 82%
- This article provides an overview of market performance on Monday, December 1st, 2025, noting a "risk off" session with all major indices closing lower, and highlights key movements in futures, bonds, oil and gas, gold, and cryptocurrencies. It then details top Wall Street analyst upgrades, downgrades, and initiations for several companies, including Albemarle, Six Flags, Inspire Medical Systems, Circle Internet Group, Cloudflare, Danaher, and Workday, among others, for Tuesday, December 2nd, 2025.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 10, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | Deutsche Bank | $125 | $110 | +14% |
| 2025-12-02 | Baird | $113 | $81 | +40% |
| 2025-11-19 | BMO Capital | $136 | $125 | +9% |
| 2025-11-13 | UBS | $107 | $85 | +26% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | Deutsche Bank | main | Hold |
| 2025-12-02 | Baird | up | Neutral |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-13 | UBS | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.8%)
- Capital World Invest: 7.0% (+0.2%)
- Blackrock Inc.: 7.0% (-0.1%)
- State Street Corpora: 4.8% (-15.4%)
- Franklin Resources, : 2.8% (-42.8%)

### Key Risks

1. Valuation stretched: PEG 20.8x requires aggressive growth execution.
2. Elevated short interest (12.5%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 10 raises (avg +16%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 20.83 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.3x). Analyst sentiment positive (10 raises, avg +16%). Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $17.7B |
| Beta | 1.43 |
| 52W Range | $49.43 - $152.08 |
| Short Interest | 12.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 20.83 |
| Forward P/E | 117.0 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 deteriorating from 15.7% to 7.6% (-8.2% in 5 days), indicating relative weakness vs NASDAQ. Currently in upper STRENGTH zone (4.0-10.0%), cross-sectional ranking at 91st percentile. MRS_5 (-1.6%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 9.7% shows strong absolute momentum above own 20MA. Outperforming sector by 7.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.57), confirming momentum. OFD pattern: +MTN (Rally).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 7.57% (CS: 92) | Strong |
| RSI_14 | 66.0 | Neutral |
| MACD Histogram | 0.57 | Bullish |
| vs SMA20 | 1.097x | Above |
| vs SMA50 | 1.244x | Above |
| vs SMA200 | 1.634x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $126.49
- **Stop Loss:** $114.29 (9.6% risk)
- **Target:** $144.79 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 77
- **Position Value:** $9,739.73
- **Portfolio %:** 9.74%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderately constructive conditions. Fed dovish pivot expectations from weak jobs data and declining VIX suggest improving risk appetite, though narrow breadth at 51% indicates selective participation. Focus on quality sectors benefiting from rate cut expectations.*

### Earnings

**Next:** 2026-02-11 (Est: $-0.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.88 | $-0.19 | +78.3% |
| 2025Q2 | $-0.81 | $0.11 | +113.5% |
| 2025Q1 | $-0.68 | $-0.18 | +73.5% |
| 2024Q4 | $-0.67 | $-1.09 | -63.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*